Synergetics USA, Inc. (SURG) Reports Mixed Q3 Results: Beats on Bottom Line, Misses on Sales
Synergetics USA, Inc. (NASDAQ: SURG) reported Q3 EPS of $0.07, $0.01 better than the analyst estimate of $0.06. Revenue for the quarter came in at $14.7 million versus the consensus estimate of $14.91 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- New Oriental Education (EDU) Misses Q1 EPS by 13c; Will Launch 'Optimize the Market' Strategy
- Aaron's (AAN) Misses Q3 EPS Views; Comps Fell 2.8%
- Magellan Health (MGLN) Tops Q3 EPS Views; Boosts FY14 EPS Outlook
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!